Fulminant BCG Disease in a 7 Month Old Healthy Male Infant

Shreya Sharma1, Vasanthan Tanigasalam1, Narayanan Parameswaran2

  • 1Department of Pediatrics, JIPMER, Puducherry-6, India.

Insights

A severe disseminated mycobacterial infection occurred in a 7-month-old infant, originating from the Bacille Calmette-Guérin (BCG) vaccination site. The infection led to widespread skin lesions, fever, and ultimately, the infant's death.

Area of Science:

  • Pediatric infectious diseases
  • Dermatology
  • Microbiology

Background:

  • Disseminated mycobacterial infections are rare but serious complications, particularly in infants.
  • The Bacille Calmette-Guérin (BCG) vaccine, used for tuberculosis prevention, can rarely lead to localized or disseminated infection.
  • Early recognition and diagnosis are crucial for managing severe pediatric infections.

Observation:

  • A 7-month-old infant presented with generalized papular skin lesions that rapidly progressed to ulceration.
  • Clinical signs included fever, irritability, tachycardia, tachypnea, and an ulcerated BCG scar with discharge.
  • The infant exhibited pancytopenia, indicating bone marrow involvement.

Findings:

  • Acid-fast bacilli were identified in skin lesions and at the BCG scar site, confirming mycobacterial infection.
  • The clinical presentation and laboratory findings were consistent with disseminated BCG infection or a similar mycobacterial disease.
  • Despite medical intervention, the infant's condition deteriorated progressively.

Implications:

  • This case highlights the potential for severe, disseminated infections following BCG vaccination in infants.
  • It underscores the importance of considering mycobacterial infections in infants presenting with unexplained skin lesions and systemic symptoms.
  • Prompt microbiological investigation and appropriate antimicrobial therapy are critical for improving outcomes in such cases.

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
27
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
707
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.1K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
3.1K
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
34